Hochfeld

About Hochfeld

A dynamic, results-oriented global broad-based Clinical Development and Medical Affairs senior leader with more than 20 years of experience in the biopharmaceutical industry (large, mid-sized, and small companies) with demonstrated success and a passion for bringing new therapeutic options to patients. Proven results leading drug development from early Phase 2 through registration and lifecycle management. Broad strategic and operational leadership in managing, prioritizing, and advancing pipeline assets.Established the strategic direction for the programs and was responsible for the oversight of worldwide submissions and approvals of 4 assets [(Sotykto (deucravacitinib), Otezla, Zeposia, Krystexxa (pegloticase), including new indications and line extensions across various therapeutic areas and indications, including Dermatology, Rheumatology, GI and Multiple Sclerosis. Successful medical affairs launch readiness preparation and launches of multiple assets across diverse therapeutic areas and a range of indications.Proven record of success in leading entrepreneurial as well as established growth organizations. Broad, cross-functional leader who develops motivated teams and utilizes innovative approaches to deliver superior results. Demonstrated achievement in situations requiring vision and experience-based leadership.Extensive expertise in disease areas, including Rheumatology, Dermatology, Gastrointestinal, Neuroscience, Allergy, Fibrosis (lung/NASH), and Psychiatry. Received a BS from the University of Pennsylvania, MD degree from Hahnemann University, and completed a residency in internal medicine and fellowship in rheumatology at Stanford University.

Experience

1. SVP, Global Clinical Development

   Teva Pharmaceuticals

   Jan 2023 — Present · NJ, US

   New Jersey, United States

Skills

• Pharmaceutical Industry
• Biotechnology
• Medical Affairs
• Healthcare
• Neurology
• Clinical Development
• Oncology
• Regulatory Affairs
• Lifesciences
• Clinical Research